Defibrotide for the Treatment of Endotheliitis Complicating Sars-Cov-2 Infection: Rationale and Ongoing Studies As Part of the International Defacovid Study Group

Coronavirus disease 2019 (COVID-19) is a heterogeneous clinical condition caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The initial stage of infection occurs at the time of respiratory viral invasion through angiotensin-converting enzyme 2 (ACE2) receptors in alve...

Descripción completa

Detalles Bibliográficos
Autores principales: Moraleda, Jose M., Carlo-Stella, Carmelo, Garcia-Bernal, David, Jara Rubio, Ruben, Andreu, Enriqueta, Calabretta, Eleonora, Aghemo, Alessio, Diaz-Ricart, Maribel, Palomo, Marta, Carreras, Enric, Vlodavsky, Israel, Iacobelli, Massimo, Fareed, Jawed, Castro, Pedro, Fernandez, Sara, Mo, Clifton C., Weinhouse, Gerald L., Cooke, Kenneth R., Soiffer, Robert J., Baron, Rebecca M., O'Gorman, Peter, Yanik, Gregory, Pagliuca, Antonio, Richardson, Paul G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
332.Anticoagulation and Antithrombotic Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330162/
http://dx.doi.org/10.1182/blood-2020-141872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330162/
http://dx.doi.org/10.1182/blood-2020-141872

Ejemplares similares